Menu
Recruiting NCT07311902

M-Tapa Block and Transversus Abdominal Plane Block for Postoperative Analgesia in Unilateral Open Inguinal Hernia Repair Surgery

No phase Interventional Pain Management Mtapa Block TAP Block

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: TAP Block Group, M TAPA block.
Who it may be relevant to
Registry conditions: Pain Management, Mtapa Block, TAP Block. Basic parameters: 18 years — 65 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Turkey (Türkiye)
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Comparison of Patient Satisfaction Survey and Pain Follow-up in Patients Who Underwent M-Tapa Block and Transversus Abdominal Plane Block for Postoperative Analgesia in Unilateral Open Inguinal Hernia Repair Surgery

Overview

Patients will be called to the operating room one hour before surgery and no premedication will be applied before coming to the operating room. Patients in both groups who are taken to the block room will be administered 1-2 mg iv midazolam for sedation. M TAPA block will be applied for the surgical procedure. After aseptic conditions are provided, the high-frequency linear US probe will be covered with a sterile sheath. The US probe will be placed in the saggital plane at the costochondral angle where the midclavicular line intersects the costal cartilage. 5 ml of saline will be injected using the in-plane technique using a 22G 100 mm block needle and the block location will be verified. After the block location is verified, a total of 20 ml of 0.25% bupivacaine will be injected unilaterally and the procedure will be terminated. After aseptic conditions are provided, the high-frequency linear US probe will be covered with a sterile sheath. In TAP block, the block needle will be advanced to the fascial plane between the internal oblique and transversus abdominis muscles with the in-plane technique and the procedure will be completed by injecting 5 ml 20 ml 0.25% bupivacaine unilaterally. The same analgesia protocol will be applied to both groups intraoperatively and postoperatively, and a survey will be conducted on the patients at the 24th hour postoperatively.

Interventions

  • Procedure TAP Block Group
    20 ml of 0.25% bupivacaine
  • Procedure M TAPA block
    20 ml of 0.25% bupivacaine

Primary outcome measures

  • pain score [Time frame: The primary aim of our study was to compare VAS scores at 1, 2, 4, 8, 12, and 24 hours postoperatively and to evaluate the level of comfort.]
Secondary outcome measures (1)
  • The QoR-15 Patient Questionnaire, a 40-question global recovery rating system with a Turkish variant [Time frame: 24 hours following surgery.]

Eligibility criteria

Exclusion criteria

  • History of bleeding diathesis
  • Allergy or sensitivity to local anesthetics and opioids
  • Infection in the area where the block will be applied
  • Alcohol or drug addiction
  • Patients with a BMI > 30
  • Suspected pregnancy
  • Women in pregnancy or lactation
  • Patients with allergies to study drugs
  • Patient refusal
  • Use of anticoagulant agents

Inclusion criteria

  • Planning for elective unilateral open inguinal hernia repair surgery
  • ASA I-II status
  • Being between 18 and 65 years of age

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Double blind
Primary purpose
Other

Study locations

Turkey (Türkiye) · 1 center
  • Erzurum Regional Education and Research Hospital — Erzurum

Identifiers

NCT: NCT07311902 · B.30.2.YYU.0.01.00.00/93

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗